Onyx Biotec

Onyx Biotec

45.25
-0.50
(-1.09%)
Market Cap
83.00 Cr
EPS
3.31
PE Ratio
19.42
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
97.45
52 Week Low
45.00
PB Ratio
1.48
Debt to Equity
0.53
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Onyx Biotec: Weak Market Debut with 11.5% Discount on ListingNov 22, 2024
Onyx Biotec listed at ₹54 on NSE SME, 11.5% below its IPO price of ₹61. The stock recovered slightly post-listing to ₹56.75. The ₹29.34 crore IPO was oversubscribed 198 times. Proceeds will be used for manufacturing upgrades, loan repayment, and corporate purposes.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,656.00
#1 3,95,554.40
34.64
#1 54,729.00
9.71
#1 10,980
-19.84
59.47
6,200.00
1,62,254.40
71.36
9,712.00
18.67
2,191
26.74
48.13
1,575.80
1,27,472.40
23.60
28,409.50
7.12
5,291
9.88
56.43
3,629.20
1,20,737.00
60.86
11,539.40
6.99
1,911
19.91
48.09
1,321.70
1,10,388.70
19.43
33,741.20
16.73
5,725
1.26
62.90
2,660.60
1,08,890.20
58.10
12,744.20
#1 20.90
2,007
-18.14
62.57
1,037.30
1,05,438.20
22.38
23,511.00
18.55
4,615
2.60
66.99
2,055.60
93,467.30
25.39
22,909.50
13.74
3,306
#1 51.64
65.03
30,365.00
65,639.10
44.33
6,684.70
9.64
1,414
11.55
38.96
1,119.20
65,566.70
#1 19.32
32,345.60
9.43
3,484
-10.24
65.06

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
36.11 %
Net Income Growth
66.67 %
Cash Flow Change
-6.58 %
ROE
20.34 %
ROCE
48.45 %
EBITDA Margin (Avg.)
34.69 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
45
40
54
63
0
Expenses
39
35
45
52
0
EBITDA
6
5
9
12
0
Operating Profit %
13 %
11 %
16 %
17 %
0 %
Depreciation
1
2
2
3
0
Interest
1
1
2
2
0
Profit Before Tax
4
3
5
7
0
Tax
0
1
1
2
0
Net Profit
3
2
4
5
0
EPS in ₹
2.84
1.56
3.05
3.31
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
37
59
74
91
Fixed Assets
17
43
44
41
Current Assets
14
15
30
49
Capital Work in Progress
4
0
0
0
Investments
0
0
0
0
Other Assets
16
16
31
50
Total Liabilities
37
59
74
91
Current Liabilities
10
20
23
26
Non Current Liabilities
10
20
26
10
Total Equity
16
18
25
56
Reserve & Surplus
11
12
12
38
Share Capital
6
6
13
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-0
-4
2
7
Investing Activities
-6
-23
-3
1
Operating Activities
1
2
2
1
Financing Activities
5
16
3
5

Share Holding

% Holding
Nov 2024
Mar 2025
Promoter
65.10 %
65.10 %
FIIs
0.00 %
0.00 %
DIIs
0.03 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
18.96 %
18.97 %
Others
15.92 %
15.94 %
No of Share Holders
1,181
551

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Jan 2025 90.15 78.95
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 49.25 49.90

Technical Indicators

RSI(14)
Neutral
37.16
ATR(14)
Less Volatile
1.49
STOCH(9,6)
Neutral
25.23
STOCH RSI(14)
Oversold
16.00
MACD(12,26)
Bearish
-0.32
ADX(14)
Weak Trend
11.29
UO(9)
Bearish
41.37
ROC(12)
Downtrend And Accelerating
-8.12
WillR(14)
Oversold
-89.15